Loading clinical trials...
Loading clinical trials...
Direct Lentiviral TYF-ARSA Injection Gene Therapy for Metachromatic Leukodystrophy (MLD)
Conditions
Interventions
Intrathecal and intravenous LV gene therapy
Locations
1
China
Lung-Ji Chang
Shenzhen, Guangdong, China
Start Date
May 31, 2025
Primary Completion Date
May 31, 2025
Completion Date
December 31, 2030
Last Updated
June 26, 2025
NCT07046338
NCT01372228
NCT01510028
NCT01963650
NCT01043640
Lead Sponsor
Shenzhen Geno-Immune Medical Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions